High Court of Australia goes cold on patentability of isolated nucleic acid
In a highly anticipated decision, the High Court of Australia has unanimously determined that an isolated nucleic acid (coding for mutations in the BRCA1 gene, associated with breast and ovarian...
View ArticleHigh Court upholds earlier decision that AstraZeneca's cholesterol-lowering...
In a closely-watched patent decision, the High Court has unanimously dismissed AstraZeneca's appeal concerning its low-dose patent for the cholesterol-lowering drug rosuvastatin (AstraZeneca AB v...
View ArticleExtract from Biotechnology & Pharmaceuticals Roundtable 2015
Colin Loveday joins an expert panel to discuss how to build and monetise a patent portfolio, the opportunities from biologics, and the challenges of an ageing population and growing life expectancy.
View ArticleInnovators to be hardest hit by PBS Access and Sustainability Package
Innovator pharmaceutical companies will be the hardest hit from the statutory price reductions, price disclosure changes and the speed with which generic drugs can obtain Pharmaceutical Benefits Scheme...
View ArticleThe International Comparative Legal Guide to Litigation 2015
Colin Loveday and Scott Grahame explain the basics of litigation and dispute resolution in Australia. This article appeared in the 2015 edition of The International Comparative Legal Guide to:...
View ArticleAustralia gets compulsory patent licensing laws for pharmaceutical exports to...
James Neil and Richard Hoad say that pharmaceutical patent holders need to be aware that, if someone asks for a licence for export to developing countries, refusal could result in an application to the...
View ArticleThe International Comparative Legal Guide to Pharmaceutical Advertising 2014
Colin Loveday and Greg Williams explain the basics of Australian pharmaceutical advertising law in this chapter excerpted from Global Legal Group's International Comparative Legal Guide to...
View ArticleAnother successful CLE Intensive series draws to a close
Clayton Utz clients in three cities got a great opportunity to get many CLE points in one hit at our CLE Intensive.
View ArticleMethods of medical treatment patentable in Australia; infringement by...
The High Court's finding in Apotex Pty Ltd v Sanofi-Aventis [2013] HCA 50 that a method of medical treatment can be a "manner of manufacture" and thus a patentable invention, is not only consistent...
View ArticleThe International Comparative Legal Guide to Pharmaceutical Advertising 2012
Colin Loveday and Greg Williams explain the basics of Australian pharmaceutical advertising law in this chapter excerpted from Global Legal Group's International Comparative Legal Guide to...
View ArticleImplementing the TRIPS Agreement in Australia - what's happening?
In November 2001, Doha, Qatar held the fourth WTO Ministerial Conference which adopted what is known as the Doha Declaration on the TRIPS Agreement and Public Health. Key to the Doha Declaration was...
View ArticleProduct Risk Annual Review 2011
In our sixth annual review of product risk developments, we review decisions by Australian courts relevant to manufacturers, suppliers and insurers who do business in Australia.
View ArticleIt lives! ANZTPA rises from the dead
The joint Australian and New Zealand therapeutic goods agency is back on the agenda.
View ArticleIs this a watershed moment for products containing nanoparticles?
There's emerging evidence of potential toxicity of zinc oxide and titanium dioxide nanoparticles. What will this mean for manufacturers of products containing nanoparticles generally, asks Dr Michael...
View ArticleSenate Committee recommends against banning gene patents
The Senate appears likely to reject the proposal to exclude "biological materials" from patentable subject matter in Australia, as Deborah Polites and Richard Hoad explain.
View ArticleFederal Court rules on copyright in pharmaceutical product information documents
In the recent case between Sanofi-Aventis Australia Pty Ltd and Apotex Pty Ltd [2011] FCA 846, the Federal Court of Australia addressed for the first time the issues of copyright subsistence and...
View ArticleThe International Comparative Legal Guide to Pharmaceutical Advertising 2011
Colin Loveday and Greg Williams explain the basics of Australian pharmaceutical advertising law in this chapter excerpted from Global Legal Group's International Comparative Legal Guide to...
View ArticleACIP report into patentability goes some way to clarifying patent law
The Advisory Council on Intellectual Property has released its Report into Patentable Subject Matter, and its recommendations, while not radical, would go some way to clarifying the law of patents in...
View ArticleNew South Wales introduces pre-litigation procedures - but what will they...
New South Wales has introduced new pre-litigation requirements, but whether they go substantially beyond litigation best practice, or how they will operate, is still unclear.
View ArticleNSW rolls back contentious cy-pres rule in class actions bill
The NSW Government has removed the contentious provision in its class actions bill allowing the Supreme Court to distribute the undistributed part of a fund of damages to charities or public interest...
View Article
![[QLD, NSW, VIC] Samsung 65](http://files.ozbargain.com.au/n/31/978831l.jpg?h=8d64f0c6)
